-
Wind Lidar Digitalization
Wind lidar technology has been increasingly used for wind energy applications for over a decade. During this time there has been an impressive development of a lidar community... -
dedup_wf_001--35b60e6bc5862c95f994b770eae5e556
Table S1. The cervical microbiota in the LEEP group and the Reference group in women aged <46 years. Table S2. The cervical microbiota six months post treatment in the LEEP... -
The risk of gastrointestinal bleeding in patients receiving dabigatran etexil...
Background: Evidence on the risk of gastrointestinal (GI) bleeding associated with dabigatran etexilate (DE) is contrasting. We performed a meta-analysis of literature to... -
Additional file 2 of The current landscape of pre-exposure prophylaxis servic...
Additional file 2. Inclusion criteria for article selection. Overview of the inclusion criteria for article selection during tiab-screening and full-text reading. -
dedup_wf_001--2666437248db00205fb00fdce370bc3f
Self-medication Questionnaire Responses. The data comprises the results of the questionnaires administered to 372 pregnant women attending antenatal clinic in Tanzania to assess... -
dedup_wf_001--c53fded2e6e140a762e8fc4af3698e38
Table 4. Exclusions and justifications. A complete listing of all drugs excluded from analysis and justifications (DOCX 17 kb) -
dedup_wf_001--70b72dc164aa915c23dd47e951edbd42
Objective: Vaginal progesterone and cervical pessary are both shown to be effective in preventing preterm. We conducted a meta-analysis to evaluate whether the combination of... -
MOESM4 of Peripheral neuropathy in metachromatic leukodystrophy: current stat...
Additional file 4: Table S3. Ongoing clinical trials on metachromatic leukodystrophy (MLD). A summary of the ongoing clinical trials on treatment for metachromatic... -
Additional file 1 of Would treatment decisions about secondary prevention of ...
Additional file 1: Supplementary appendix REACH-SMART model1. Supplemental table 1. Annual event risks and mortality multipliers. Supplemental table 2. Costs and utilities.... -
Additional file 5 of The current landscape of pre-exposure prophylaxis servic...
Additional file 5. Detailed overview of study design and main findings of the included literature. More detailed insight into the study design of the included records and their... -
dedup_wf_001--6b045eabe5af17717c92a951ca5861f2
Additional file 1: Table S1. National Drug Codes (NDC) for Varenicline. This supplementary table includes the full list of national drug codes for all varenicline formulations.... -
Preparation and unequivocal identification of the regioisomers of nitrocatech...
ABSTRACTThe four positional isomers of nitrocatechol monobenzyl ether were prepared as intermediates to nitrobenzodioxanes directly from 2-benzyloxyphenol or, through two-four... -
MOESM1 of Availability, accessibility and delivery to patients of the 28 orph...
Additional file 1: Table S1. Questionnaire addressed to MetabERN centres. Table S2. Responding centres. Table S3. List of the 28 EMA-approved OMPs for HMDs. Table S4. List of... -
Additional file 1 of Clinical pictures, treatments, and resource use of norov...
Additional file 1. Questionnaires of Surveys I. -
Additional file 1: of Medicaid prescription limits: policy trends and compara...
Online methods. Online results. Online Table S1. Sources of policy information organized by state. Online Table S2. Missing state policy information. Online Table S3. Proportion... -
Additional file 2 of Clinical characteristics of 9 cancer patients with SARS-...
Additional file 2: Table S1. General information and Clinical manifestations of cancer patients with 2019-nCoV infection. -
dedup_wf_001--679ac0e006faddef52ba4b485d19cf5e
cardiovascular disease event incidence (per 1000 person-year) of different serum lipid markers and lipid indices among men, women and total participants (n=5054); Tehran Lipid... -
Additional file 2 of Environmental assessment of cytotoxic drugs in healthcar...
Additional file 2: Table S2. IARC classification of cytotoxic drugs. -
Additional file 4 of Design of a care pathway for pharmacy-based PrEP deliver...
Additional file 4: Appendix IV. Pharmacy PrEP prescribing Checklist. -
Additional file 3: of Use of health outcome and health service utilization in...
Evaluation of health outcomes indicators; his box presents the detailed evaluation made about each indicator of health outcome from the papers retained in this research. (PDF 63...
